Wall Street analyst price targets, ratings consensus & upside potential · Updated Mar 27, 2026
Last 12 months price action with 12-month analyst target path
As of May 10, 2026, BioHarvest Sciences Inc. Common Stock (BHST) has a Wall Street consensus price target of $10.00, based on estimates from 1 covering analysts. With the stock currently trading at $3.97, this represents a potential upside of +151.9%. The company has a market capitalization of $90M.
Analyst price targets range from a low of $10.00 to a high of $10.00, representing a 0% spread in expectations. The median target of $10.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BHST trades at a trailing P/E of -5.0x. Analysts expect EPS to grow +80.2% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonQuick answers to the most common questions about buying BHST stock.
The consensus Wall Street price target for BHST is $10, representing 151.9% upside from the current price of $3.97. With 1 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BHST has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $10 implies 151.9% upside from current levels.
BHST's current price is $3.97 with a consensus target of $10 (151.9% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $10 for BHST, while the most conservative target is $10. The consensus of $10 represents the median expectation. These targets typically reflect 12-month expectations.
BHST is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BHST stock forecast based on 1 Wall Street analysts shows a consensus price target of $10, with estimates ranging from $10 (bear case) to $10 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on BHST, with a "Buy" consensus rating and $10 price target (151.9% upside). 1 of 1 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BHST analyst price targets range from $10 to $10, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10 consensus represents the middle ground.